Bioatla Announces FDA Clearance of Investigational New Drug Application for Ba3361, a Cab-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
Bioatla宣布FDA批准Ba3361的研究性新药申请,Ba3361是一种用于治疗多种肿瘤的Cab-Nectin-4抗体偶联物
Bioatla Announces FDA Clearance of Investigational New Drug Application for Ba3361, a Cab-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
Bioatla宣布FDA批准Ba3361的研究性新药申请,Ba3361是一种用于治疗多种肿瘤的Cab-Nectin-4抗体偶联物
使用浏览器的分享功能,分享给你的好友吧